<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03264807</url>
  </required_header>
  <id_info>
    <org_study_id>NCC2015-0188</org_study_id>
    <nct_id>NCT03264807</nct_id>
  </id_info>
  <brief_title>Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer</brief_title>
  <official_title>A Multicenter Randomized Controlled Trial of D2 Versus D2 + Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer (14VIGTORY Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the survival rate according to the presence or
      absence of 14v lymph node dissection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare the survival rate according to the presence or
      absence of 14v lymph node dissection. Actually, if the 14v lymph node metastasis is suspected
      before surgery, it is excluded from the study. In a retrospective study conducted in our
      hospital, we compared the patients with the 14v lymphadenectomy group and those without the
      14v lymphadenectomy group, the survival rate of the 14v lymphadenectomy group was 11% higher
      than that of the 14v non-lymphadenectomy group.Previous studies have suggested that the
      presence of metastatic lymph nodes in the 14v lymph node is not good and that removal of the
      14v lymph node does not affect prognosis. However, if the lymph node is a continuous tissue
      and the transition to the 14v lymph node is confirmed microscopically, a negative prognosis
      may be expected because it is likely that the cancer has spread to the distal lymph node. In
      addition, inadequate resection of the lymphatic or 14v lymph node adjacent to the 14v lymph
      node in the absence of evidence of metastasis of the 14v lymph node under microscopic
      examination indicates that cancer may spread even after curative surgery, To prevent cancer
      metastasis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Superiority verification of disease-free survival after lymphadenectomy for D2 + 14v lymph node dissection in gastric resection in patients with T3N + and T4N + stomach cancer</measure>
    <time_frame>the last recruited patient was followed up for 3 years</time_frame>
    <description>Patients were randomized to an intention-to-treat population. The primary efficacy assessment was performed at the end of the 3-year follow-up period. The free-disease survival rates of the two groups were compared by log rank test.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">518</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>D2 lymphadenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subtotal gastrectomy with D2 lymphadnectomy (lymph node #1, #3, #4sb, #4d, #5, #6, #7, #8a, #9, #11p, #12a) could be performed in this arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D2 and #14v lymphadenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subtotal gastrectomy with D2 (lymph node #1, #3, #4sb, #4d, #5, #6, #7, #8a, #9, #11p, #12a) and lymph node #14v lymphadnectomy could be performed in this arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>D2 lymphadenectomy</intervention_name>
    <description>Subtotal gastrectomy with D2 lymphadenectomy (lymph node #1, #3, #4sb, #4d, #5, #6, #7, #8a, #9, #11p, #12a) is conventional surgery in patients with advanced gastric cancer such as T3N+ or T4N+ stage.</description>
    <arm_group_label>D2 lymphadenectomy</arm_group_label>
    <other_name>Subtotal gastrectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>D2 and #14v lymphadenectomy</intervention_name>
    <description>Subtotal gastrectomy with D2 (lymph node #1, #3, #4sb, #4d, #5, #6, #7, #8a, #9, #11p, #12a) and #14v lymphadenectomy is experimental surgery in patients with advanced gastric cancer such as T3N+ or T4N+ stage.</description>
    <arm_group_label>D2 and #14v lymphadenectomy</arm_group_label>
    <other_name>Subtotal gastrectomy</other_name>
    <other_name>D2 lymphadenectomy</other_name>
    <other_name>#14v lymphadenectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        &lt;Inclusion Criteria&gt;

          -  Histologically proven primary gastric adenocarcinoma

          -  T3N+, T4N+ by CT scan (AJCC 7th classification)

          -  Distal margin of gastric cancer Location of distal margin of gastric cancer ; antrum,
             or angle of the stomach

          -  No evidence of other distant metastasis

          -  Age â‰¥ 20 year old

          -  Performance status (PS) of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale

          -  No prior treatment of chemotherapy or radiation therapy against any other
             malignancies, and no prior treatment for gastric cancer including endoscopic mucosal
             resection

          -  Adequate organ functions defined as indicated below:

               1. WBC 3000/mm3 - 12,000/mm3

               2. &gt; Serum Hemoglobin 8.0 g/dl

               3. &gt; Serum Platelet 100 000/mm3

               4. &lt; Serum AST 100 IU/l

               5. &lt;Serum ALT 100 IU/l

               6. &lt; Total Bilirubin 2.0 mg/dl

          -  Written signed informed consent

        &lt;Exclusion Criteria&gt;

          -  Active double cancer (synchronous double cancer and metachronous double cancer within
             five disease-free years), excluding carcinoma in situ (lesions equal to
             intraepithelial or intramucosal cancer)

          -  Gastric remnant cancer

          -  Pregnant or breast-feeding women

          -  Mental disorder(diagnosed with mental disorder on medical record)

          -  Systemic administration of corticosteroids(include Herbal Medication)

          -  Unstable angina or myocardial infarction within 6 months of the trial

          -  Unstable hypertension

          -  Severe respiratory disease requiring continuous oxygen therapy

          -  Previous upper abdominal surgery except laparoscopic cholecystectomy

          -  Indications Total gastrectomy

          -  Borrmann type IV in the preoperative examination (including localized)

          -  Suspected LN # 14v metastasis during surgery

          -  Indications Pancreatectomy

          -  Suspected a metastasis of CT scans LN # 13, LN # 14

          -  Clinical stage IV group is suspected or confirmed during surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HONG MAN YOON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>HONG MAN YOON, MD</last_name>
    <phone>+82-31-920-1710</phone>
    <email>red10000@ncc.re.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Catholic University of Korea, Incheon St. Mary'S Hospital</name>
      <address>
        <city>Incheon</city>
        <state>Bupyeong-gu</state>
        <zip>21431</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jinjo Kim, doctor's</last_name>
      <email>kjj@catholic.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dankook University Hospital</name>
      <address>
        <city>Chungcheong</city>
        <state>Cheonan-si</state>
        <zip>31116</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ye Sub Ji, doctor's</last_name>
      <phone>010-2523-7271</phone>
      <email>ysjee@dkuh.co.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dongnam Inst. of Radiological &amp; Medical Sciences</name>
      <address>
        <city>Busan</city>
        <state>Gijang-gun</state>
        <zip>46033</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jaesuck Min, doctor's</last_name>
      <phone>+82-10-9567-9788</phone>
      <email>mdoogy@hanmail.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gyeongsang national university hospital</name>
      <address>
        <city>Gyeongsang</city>
        <state>Gingu-si</state>
        <zip>52727</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giho park, MD</last_name>
      <email>goodgsdr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>youngjun Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Gyeonggi-do</city>
        <state>Goyang-si</state>
        <zip>10408</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Man Yoon, doctor's</last_name>
      <phone>+82-01-6356-8426</phone>
      <email>red10000@ncc.re.kr</email>
    </contact>
    <investigator>
      <last_name>YOUNG WOO KIM, doctor's</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bang Wool Eom, doctor's</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Keun Won Ryu, doctor's</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>catholic university of korea,Seoul ST. Mary's Hospital.</name>
      <address>
        <city>Seocho</city>
        <state>Seoul</state>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanhong Lee, doctor's</last_name>
      <phone>+82-01-4326-6039</phone>
      <email>painKiller9@catholic.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Hoseok Seo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Sincon</state>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyung-Il Kim, master's</last_name>
      <phone>+82-10-2224-4986</phone>
      <email>cairus@yuhs.ac</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Songpa-gu</state>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Hwan Yook, doctor's</last_name>
      <phone>010-2258-8826</phone>
      <email>jhyook@amc.seoul.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>A JOU University medical center</name>
      <address>
        <city>Gyeonggi-do</city>
        <state>Suwon-si</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hoom hur, doctor's</last_name>
      <phone>010-9065-5944</phone>
      <email>hhcmc75@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pusan National University Yangsan Hospital</name>
      <address>
        <city>Gyeongsang</city>
        <state>Yangsan-si</state>
        <zip>50612</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sunhee Hwang, doctor's</last_name>
      <email>shhwang@pnuyh.co.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2017</study_first_submitted>
  <study_first_submitted_qc>August 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2017</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Hong Man Yoon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Lymph Node 14v</keyword>
  <keyword>D2 lymphadenectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

